Problem-Solving Treatment for People Recently Diagnosed with Visual Impairment: Pilot Randomised Controlled Trial

Afsane Riazi, Trefor Aspden, Gary Rubin, Gareth Ambler, Fatima Jichi, Laurence Mynors-Wallice, Miriam O'Driscoll, Kate Walters

Research output: Contribution to journalArticlepeer-review

19 Downloads (Pure)

Abstract

Background: Problem-Solving Treatment (PST) has been used to treat and prevent depression in a variety of settings. However, the impact of PST on improving psychological well-being in those with recent vision loss remains unknown. The aim of this study was to evaluate whether PST may lead to better psychological well-being in people with recent vision loss through a pilot parallel-group randomised controlled trial. Methods: Participants who were diagnosed with visual impairment during the previous 3 months were randomly allocated to either an 8-week PST or treatment as usual (N = 61). Outcome measures were administered at baseline, 3, 6, and 9-months. Results: A linear mixed model demonstrated that PST significantly improved psychological well-being (measured by the Warwick Edinburgh Mental Well-being Scale) (treatment effect = 2.44; 95% CI = 0.40–4.47; p = 0.019). Significant improvements in the PST group for symptoms of distress, quality of life and self-efficacy were also observed. There was no significant difference in mobility. The treatment effect was consistent at all follow-ups. Attrition rate was low (13%). Conclusions: PST was associated with a significant and sustained improvement in a range of outcomes in people with recent vision loss. Further large scale RCT is now required.
Original languageEnglish
Article number1431
Number of pages11
JournalJournal of Personalized Medicine
Volume12
Issue number9
DOIs
Publication statusPublished - 31 Aug 2022
Externally publishedYes

Keywords

  • problem-solving treatment
  • psychological well-being
  • quality of life
  • vision loss
  • visual impairment

Fingerprint

Dive into the research topics of 'Problem-Solving Treatment for People Recently Diagnosed with Visual Impairment: Pilot Randomised Controlled Trial'. Together they form a unique fingerprint.

Cite this